JNBA Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $92.8K | Hold |
185
| – | – | 0.01% | 252 |
|
|
2026
Q1 | $90.9K | Sell |
185
-2
| -1% | -$1.08K | 0.01% | 243 |
|
|
2025
Q4 | $108K | Buy |
187
+6
| +3% | +$3.39K | 0.01% | 233 |
|
|
2025
Q3 | $87.8K | Hold |
181
| – | – | 0.01% | 245 |
|
|
2025
Q2 | $73.4K | Hold |
181
| – | – | 0.01% | 254 |
|
|
2025
Q1 | $90.1K | Hold |
181
| – | – | 0.01% | 226 |
|
|
2024
Q4 | $94.2K | Hold |
181
| – | – | 0.01% | 223 |
|
|
2024
Q3 | $112K | Hold |
181
| – | – | 0.01% | 214 |
|
|
2024
Q2 | $100K | Sell |
181
-12
| -6% | -$6.88K | 0.01% | 221 |
|
|
2024
Q1 | $112K | Hold |
193
| – | – | 0.01% | 218 |
|
|
2023
Q4 | $102K | Sell |
193
-15
| -7% | -$7.26K | 0.01% | 226 |
|
|
2023
Q3 | $105K | Buy |
208
+4
| +2% | +$2.13K | 0.01% | 222 |
|
|
2023
Q2 | $106K | Buy |
204
+3
| +1% | +$1.62K | 0.01% | 222 |
|
|
2023
Q1 | $116K | Sell |
201
-35
| -15% | -$19.7K | 0.02% | 220 |
|
|
2022
Q4 | $130K | Sell |
236
-3
| -1% | -$1.59K | 0.02% | 211 |
|
|
2022
Q3 | $121K | Sell |
239
-4
| -2% | -$2.24K | 0.02% | 210 |
|
|
2022
Q2 | $132K | Sell |
243
-19
| -7% | -$10.5K | 0.02% | 204 |
|
|
2022
Q1 | $155K | Sell |
262
-11
| -4% | -$6.32K | 0.02% | 203 |
|
|
2021
Q4 | $182K | Buy |
273
+14
| +5% | +$8.74K | 0.02% | 197 |
|
|
2021
Q3 | $148K | Buy |
259
+23
| +10% | +$12.6K | 0.02% | 207 |
|
|
2021
Q2 | $119K | Hold |
236
| – | – | 0.02% | 217 |
|
|
2021
Q1 | $108K | Buy |
236
+40
| +20% | +$19.1K | 0.02% | 217 |
|
|
2020
Q4 | $91K | Buy |
196
+115
| +142% | +$53.9K | 0.02% | 214 |
|
|
2020
Q3 | $36K | Buy |
81
+3
| +4% | +$1.24K | 0.01% | 277 |
|
|
2020
Q2 | $28K | Hold |
78
| – | – | 0.01% | 295 |
|
|
2020
Q1 | $22K | Hold |
78
| – | – | 0.01% | 297 |
|
|
2019
Q4 | $25K | Hold |
78
| – | – | ﹤0.01% | 327 |
|
|
2019
Q3 | $23K | Sell |
78
-9
| -10% | -$2.58K | ﹤0.01% | 319 |
|
|
2019
Q2 | $26K | Hold |
87
| – | – | 0.01% | 312 |
|
|
2019
Q1 | $24K | Hold |
87
| – | – | 0.01% | 310 |
|
|
2018
Q4 | $19K | Buy |
+87
| New | +$20.4K | ﹤0.01% | 302 |
|
|
2018
Q3 | – | Sell |
-87
| Closed | -$18K | – | 697 |
|
|
2018
Q2 | $18K | Hold |
87
| – | – | ﹤0.01% | 326 |
|
|
2018
Q1 | $18K | Hold |
87
| – | – | ﹤0.01% | 322 |
|
|
2017
Q4 | $17K | Hold |
87
| – | – | ﹤0.01% | 330 |
|
|
2017
Q3 | $16K | Hold |
87
| – | – | ﹤0.01% | 324 |
|
|
2017
Q2 | $15K | Hold |
87
| – | – | ﹤0.01% | 321 |
|
|
2017
Q1 | $13K | Buy |
87
+9
| +12% | +$1.38K | ﹤0.01% | 339 |
|
|
2016
Q4 | $11K | Sell |
78
-1,937
| -96% | -$286K | ﹤0.01% | 357 |
|
|
2016
Q3 | $321K | Buy |
2,015
+1,937
| +2,483% | +$298K | 0.05% | 154 |
|
|
2016
Q2 | $12K | Hold |
78
| – | – | ﹤0.01% | 338 |
|
|
2016
Q1 | $11K | Hold |
78
| – | – | ﹤0.01% | 347 |
|
|
2015
Q4 | $11K | Hold |
78
| – | – | ﹤0.01% | 340 |
|
|
2015
Q3 | $10K | Hold |
78
| – | – | ﹤0.01% | 355 |
|
|
2015
Q2 | $10K | Hold |
78
| – | – | ﹤0.01% | 354 |
|
|
2015
Q1 | $10K | Hold |
78
| – | – | ﹤0.01% | 366 |
|
|
2014
Q4 | $10K | Hold |
78
| – | – | ﹤0.01% | 360 |
|
|
2014
Q3 | $9K | Buy |
78
+33
| +73% | +$4.01K | ﹤0.01% | 382 |
|
|
2014
Q2 | $5K | Hold |
45
| – | – | ﹤0.01% | 409 |
|
|
2014
Q1 | $5K | Hold |
45
| – | – | ﹤0.01% | 385 |
|
|
2013
Q4 | $5K | Hold |
45
| – | – | ﹤0.01% | 360 |
|
|
2013
Q3 | $4K | Hold |
45
| – | – | ﹤0.01% | 360 |
|
|
2013
Q2 | $4K | Buy |
+45
| New | +$3.75K | ﹤0.01% | 316 |
|
Other funds holding TMO
RG
LT
ATO
QP
CF
JNBA Financial Advisors's TMO Position: Q2 2026 in Review
JNBA Financial Advisors held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 185 shares worth $92.8K. The position accounts for 0.01% of the portfolio, ranked #252.
JNBA Financial Advisors first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $321K in Q3 2016. 875 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- JNBA Financial Advisors held 185 shares of Thermo Fisher Scientific worth $92.8K as of Q2 2026.
- JNBA Financial Advisors left its Thermo Fisher Scientific share count unchanged in Q2 2026.
- Thermo Fisher Scientific made up 0.01% of JNBA Financial Advisors's portfolio in Q2 2026, its #252 holding.
- JNBA Financial Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- JNBA Financial Advisors's Thermo Fisher Scientific position peaked at $321K in Q3 2016.
- 875 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.